Here are five takeaways:
1. North America leads the global market, because of an increasing aging population as well as technological advancements.
2. The market will see rapid growth in China and India, due to increased medical tourism and improved healthcare infrastructure.
3. Emerging countries’ markets will grow due to increasing awareness and growing government funding.
4. Demand for minimally invasive procedures drives the global market, but steep maintenance and service costs will hinder market growth. A dearth in skilled professionals will also slow market growth.
5. Key market players include:
• B. Braun Melsungen in Germany
• Conmed Corp. in Utica, N.Y.
• Medtronic in Dublin, Ireland
• Stryker Corp. in Kalamazoo, Mich.
More articles on devices:
Flexion Therapeutics submits new drug application for knee osteoarthritis pain pill: 4 key notes
Global hip, knee implant market to hit $33B by 2022: 5 observations
SeaSpine names William Rhoda to new executive position: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
